CNC · NYSE · ·
70,30 $-0,2 %Schluss 12. Nov.
Zahlen bis 30. September 2026, aus dem 10-Q vom 27. Oktober 2026
Just reported
From Centene's results release of 27. Oktober 2026; its quarterly report has since been filed.
Actual
50,65B $
+1,9 % y/y
-5,5 % q/q
Guided
—
No guide given
Actual
-0,14 $
Guided
—
No guide given
Actual
-307M $
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Die Umsatzanteile sind Schätzungen für Q2 2026 und keine Zahlen aus einem eingereichten Bericht.
Medicaid managed-care plans
Health coverage for eligible low-income people, children, people with disabilities and others; Centene arranges care through contracted doctors, hospitals and other providers.
Medicare Advantage plans
Private health plans that provide Medicare benefits, including plans that coordinate care for people enrolled in both Medicare and Medicaid.
Medicare Prescription Drug Plans
Standalone plans that provide prescription drug coverage to people eligible for Medicare.
Ambetter Health insurance
Individual and family health insurance sold through the federal and state Health Insurance Marketplaces.
Ambetter Health Solutions plans
Individual health insurance plans compatible with employer arrangements that reimburse workers for insurance premiums and eligible medical costs.
AcariaHealth specialty pharmacy services
Pharmacy services and clinical support for people with complex or long-term health conditions, including help accessing prescribed medicines.
Centene arranges health care for people enrolled in Medicaid, Medicare and private health plans. Its largest business is Medicaid coverage, which it provides under contracts with state governments; it also sells Medicare Advantage plans, prescription drug plans and individual health insurance. It served 25.9 million members across its health plans and drug plans (June 30, 2026, high).
Gebaut aus den eigenen Einreichungen von Centene Corp. bei der US-Börsenaufsicht Securities and Exchange Commission (SEC). Die Zahlen sind wie berichtet, die Historie je Aktie auf die heutige Aktienbasis umgerechnet. Dies beschreibt ein Unternehmen — es ist keine Anlageberatung und keine Kauf- oder Verkaufsempfehlung.
The themes Centene is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Centene sells Medicaid health coverage to state governments for low-income people, plus Medicare coverage to older adults and people with disabilities.
Grade D
Das Band unter dem Kurs zeigt die Note an jedem Tag – gebildet nur aus den Unterlagen, die bis dahin veröffentlicht waren.
Zeigt 2 von 41 Quartalen der Notenhistorie von Centene Corp.. Die übrigen 39 reichen zurück bis Oktober 2016.